The t(4;9)(q11;q33) fuses CEP110 to KIT in a case of acute myeloid leukemia

被引：3

作者：

Grand, F. H. ^{[1
]}

Waghorn, K. ^{[1
]}

Ernst, T. ^{[1
]}

Ohyashiki, K. ^{[2
]}

Cross, N. C. P. ^{[1
]}

机构：

[1] Univ Southampton, Wessex Reg Genet Lab, Salisbury, Wilts, England

[2] Tokyo Med Univ, Dept Internal Med 1, Tokyo, Japan

来源：

LEUKEMIA | 2011年 / 25卷 / 06期

关键词：

D O I：

10.1038/leu.2011.40

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1049 / 1050

页数：3

共 6 条

[1] FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33) [J].

Guasch, G ;

Mack, GJ ;

Popovici, C ;

Dastugue, N ;

Birnbaum, D ;

Rattner, JB ;

Pébusque, MJ .

BLOOD, 2000, 95 (05) :1788-1796

[2] Oncogenic derivatives of platelet-derived growth factor receptors [J].

Jones, AV ;

Cross, NCP .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (23) :2912-2923

[3] Translocation (4;9)(q11;q33), a new rearrangement in acute myeloid leukemia with central nervous system involvement [J].

Liu, YC ;

Sashida, G ;

Kodama, A ;

Ohyashiki, K .

CANCER GENETICS AND CYTOGENETICS, 2006, 165 (01) :85-86

[4] Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3 [J].

Masson, Kristina ;

Ronnstrand, Lars .

CELLULAR SIGNALLING, 2009, 21 (12) :1717-1726

[5] Tyrosine kinases as therapeutic targets in BCR-ABL negative chronic myeloproliferative disorders [J].

Reiter, Andreas ;

Walz, Christoph ;

Cross, Nicholas C. P. .

CURRENT DRUG TARGETS, 2007, 8 (02) :205-216

[6] Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia [J].

Score, J ;

Curtis, C ;

Waghorn, K ;

Stalder, M ;

Jotterand, M ;

Grand, FH ;

Cross, NCP .

LEUKEMIA, 2006, 20 (05) :827-832

← 1 →